Evidence map›Paper›PMID 31635210›Full record

ArticleInternational journal of molecular sciences2019

Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing

Masazumi Teramae, Kayo Osawa, Katsumi Shigemura, Koichi Kitagawa, Toshiro Shirakawa, Masato Fujisawa, Takayuki Miyara

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Genetic Comparison of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Masazumi TeramaeDepartment of Biophysics, Kobe University Graduate School of Health Sciences, Kobe 6540142, Japan. masa_terara84@hotmail.com.
Kayo OsawaDepartment of Biophysics, Kobe University Graduate School of Health Sciences, Kobe 6540142, Japan. osawak@kobe-u.ac.jp.ORCID 0000-0002-4787-4333
Katsumi ShigemuraDivision of Infectious diseases, Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe 6540142, Japan. katsumi@med.kobe-u.ac.jp.
Koichi KitagawaDivision of Infectious diseases, Department of Public Health, Kobe University Graduate School of Health Sciences, Kobe 6540142, Japan. ko1.kitgwa@gmail.com.
Toshiro ShirakawaDivision of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 6500017, Japan. toshiro@med.kobe-u.ac.jp.
Masato FujisawaDivision of Urology, Department of Organ Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe 6500017, Japan. masato@med.kobe-u.ac.jp.
Takayuki MiyaraDepartment of Infection Prevention and Control, Kobe University Hospital, Kobe 6540142, Japan. miyarat@med.kobe-u.ac.jp.
Kobe University · JPHyogo Prefectural Awaji Medical Center · JPKobe Tokiwa University · JPKobe University Hospital · JP

Funding

undefined <span style="color:gray;font-size:10px;">undefined</span> 18K10045
6 · The paper itself

Abstract

Extended-spectrum β-lactamase (ESBL)-producing

Indexed as

Drug Resistance, BacterialAllelesAnti-Bacterial Agentsbeta-LactamasesEscherichia coliEscherichia coli InfectionsHumansJapanMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingMutationPrevalenceQuinolonesAnti-Bacterial Agentsbeta-LactamasesQuinolonesCH typingESBLEscherichia colifimHST131

Identifiers

PMID31635210
PMCPMC6829264
OpenAlexW2981228899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.